On October 2, 2014, I was diagnosed with a rare brain abnormality called a Chiari Malformation. This caused unremitting breathing difficulty and intractable seizures. That night, I underwent emergency brain surgery. Without it, my symptoms would have become fatal.
Following the surgery, I had a challenging physical and emotional recovery. Over a period of 3 months, I regained my ability to talk and use my extremities. I was able to return to Duke University the following January and graduate with my Master of Arts in Bioethics & Science Policy in 2015.
Unfortunately, as a result of the Chiari Malformation, I live with residual neurologic effects, of which include refractory seizures. Although I face these challenges, I refuse to let my condition define my future and I want to inspire this outlook for the millions of other patients who are facing emotionally and physically debilitating chronic illnesses.
Often during my seizures, I sustain oral injuries. Poor management of oral-motor symptoms, such as tongue biting and hypersalivation, may impede patients' ability to talk and eat and creates additional anxiety and feelings of embarrassment. Currently, there is not a device on the market to address these symptoms, so I decided to create one. PATI is an innovative symptom-management technology that improves the patient experience.
Your donation brings P.A.T.I. one step closer to the commercial market for millions of patients who suffer from seizures and other movement disorders. At NeuroVice, LLC we want to make having a seizure, a little easier. Please join us on our mission to improve the patient experience.
More About The CEO & Founder - Ashlyn Sanders, BA, MA
Ashlyn was born in California but has been raised in North Carolina for most of her life. She graduated from The University of North Carolina at Chapel Hill, B.A. Mathematics and Duke University, M.A. Bioethics & Science Policy. She was a former White House Intern during The Obama Administration in The Office of Science and Technology Policy and The Office of Public Engagement. She currently serves on the Wake Med Hospital Ethics Committee in Raleigh, North Carolina. She has plans to pursue a career in Neurology.
We are a finalist for a pre-seed award from the New England Pediatric Device Consortia (NEPDC).
Out of 16 startup companies, we were selected as the 2017 finalist for the 1776 Challenge Cup.
We are a regional semi-finalist for the SBA InnovateHER grant award.
P.A.T.I. Improves The Patient Experience and Enables Patient Lives
- As mentioned in the video, neurologists advise patients that objects used to prevent oral trauma or injury during neurologic episodes pose a choking hazard, cause a buildup of saliva, and obstruct respiration.
- P.A.T.I. is a disposable, structural and functional solution that prevents the patient from biting and/or injuring their tongue and jaw and from hypersalivation, which can lead to foaming at the mouth or drooling.
- It is a tongue protector that engages the tongue and allows for relative movement and is designed to be safe for a patient to use during neurologic episodes. It will be prescribed for inpatient, first responder, and outpatient use. The device will come in a kit that can be worn around the neck or placed in an accessible location. The kit will contain a wristband which lets others know the patient has the device.
- Auras or physiological or sensory changes to the body or the environment are patient's first signs of an impending seizure. Upon experiencing an aura, the patient will open their kit, remove the device, and place it inside their mouth. After the seizure, the patient will remove the device, discard it, and restock their kit with a new one. It's that simple!
- PATI allows for the natural flow of air and saliva. It can be worn at night - patients often sustain oral injuries due to nocturnal seizures. PATI comes in kid-friendly designs that make them easy and inviting for kids to use.
Patient Use Scenarios
- Charlie is 8 years old and has Epilepsy. His tonic-clonic seizures induce more severe episodes of drooling and occasional tongue biting. He has not responded well to medications.
- P.AT.I. is a cost-effective, prescription option for Charlie. He can wear the device and better manage his symptoms at home with supportive care from his family
- Value Analysis: Better, Safer, Cheaper
First To Market
- Reduce Hospital Costs and Consumer Healthcare Costs Associated with Symptom Management: Patients who are better able to manage their condition limit frequent doctor visits and avoid expensive complications over the long-term.
- Strong Physician and Patient Support: Patients, their caregivers, and healthcare providers are constantly seeking better ways to improve the patient experience.
- Safety and Ease of Use: A non-invasive resource that enhances patient safety during neurological episodes.
What We Need
- This iFundWomen Campaign will provide us with the capital that we need to develop P.A.T.I. into a working prototype. Development of a working prototype will get NeuroVice, LLC one step closer to the 510k premarket FDA approval process.
- The future of healthcare won't just be about what the healthcare provider can do for the patient, but what we as patients can do as the captains for managing our own health. At NeuroVice, LLC, we believe medical device technology will be the enabler that makes this paradigm shift possible.
North Carolina vs. All Y'all Stickers!
Coloring Books for Stress Relief and Relaxation
Organic Flax Seed Eye Pillow
Essential Oils and LED Diffuser
Four-Course Dinner for Two at Herons at the Umstead Hotel & Spa
Hero/Heroine 80-Minute Massage at The Umstead Spa
PREMIUM Carolina Panthers Home Game Tickets!
Thanks to All Y'all for Contributing!